As biomarkers continue to be explored in resectable melanoma, oncology nurses will play a crucial role in the clinical trial process.

An expert explained the role oncology nurses and advanced practice providers play in caring for patients with sarcoma during ...

Panelists discuss how axatilimab, a novel therapy for chronic graft-versus-host disease (cGVHD), functions through a unique mechanism of action compared to other treatments, highlighting its potential ...

Oral drugs in the HR-positive, HER2-negative metastatic breast cancer space put a focus on clear patient-provider ...

The FDA granted a priority review to acalabrutinib for the treatment of previously untreated adults with mantle cell lymphoma ...

Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd ...

The FDA approved neoadjuvant nivolumab plus chemo, followed by adjuvant nivolumab for non-small cell lung cancer without EGFR mutations or ALK rearrangements. The FDA approved neoadjuvant nivolumab ...

Belantamab mafodotin plus KRd had a a manageable safety profile and deep responses in pretreated multiple myeloma. Belantamab mafodotin-blmf (Blenrep) plus carfilzomib, lenalidomide (Revlimid), and ...

Panelists discuss how the current treatment landscape for chronic graft-versus-host disease includes a range of immunosuppressive approaches, from traditional corticosteroids and calcineurin ...

“We [as oncology nurses] end up establishing good rapports with our patients, and we’re basically the frontlines to nutritional deficiencies,” DiRubbo said. “So assessing nutritional needs from the ...